These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 4917915)

  • 21. Anti-neuraminidase antibody response in serum and nasal secretions following intranasal or subcutaneous inactivated A2-Hong Kong-68 influenza virus vaccine.
    Fedson DS; Fulk RV; Huber MA; Reisberg MA; Kasel JA
    J Immunol; 1971 Sep; 107(3):730-7. PubMed ID: 4999093
    [No Abstract]   [Full Text] [Related]  

  • 22. Immunity to challenge in volunteers vaccinated with an inactivated current or earlier strain of influenza A(H3N2).
    Larson HE; Tyrrell DA; Bowker CH; Potter CW; Schild GC
    J Hyg (Lond); 1978 Apr; 80(2):243-8. PubMed ID: 632564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hong Kong influenza in the Royal Air Force 1968-70.
    Miller DL; Reid D; Daimond JR; Pereira MS; Chakraverty P
    J Hyg (Lond); 1973 Sep; 71(3):535-47. PubMed ID: 4518353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High titre neutralising antibodies to influenza after oral tablet immunisation: a phase 1, randomised, placebo-controlled trial.
    Liebowitz D; Lindbloom JD; Brandl JR; Garg SJ; Tucker SN
    Lancet Infect Dis; 2015 Sep; 15(9):1041-1048. PubMed ID: 26333337
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial.
    Stephenson I; Nicholson KG; Glück R; Mischler R; Newman RW; Palache AM; Verlander NQ; Warburton F; Wood JM; Zambon MC
    Lancet; 2003 Dec; 362(9400):1959-66. PubMed ID: 14683655
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative trial of influenza vaccines. I. Immunogenicity of whole virus and split product vaccines in man.
    Barry DW; Mayner RE; Staton E; Dunlap RC; Rastogi SC; Hannah JE; Blackburn RJ; Nortman DF; Graze PR
    Am J Epidemiol; 1976 Jul; 104(1):34-46. PubMed ID: 947145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparative trials of live attenuated and detergent split influenza virus vaccines.
    Mackenzie JS; Mackenzie I; Lloyd J; Dent V
    J Hyg (Lond); 1975 Dec; 75(3):425-43. PubMed ID: 1059709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reactogenicity and immunogenicity of a surface-antigen-adsorbed influenza virus vaccine in children.
    Eastwood LM; Jennings R; Milner RD; Potter CW
    J Clin Pathol; 1979 Jun; 32(6):534-7. PubMed ID: 469010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.
    Knight V; Couch RB; Douglas RG; Tauraso NM
    Bull World Health Organ; 1971; 45(6):767-71. PubMed ID: 5317012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus vaccine live intranasal--MedImmune vaccines: CAIV-T, influenza vaccine live intranasal.
    Drugs R D; 2003; 4(5):312-9. PubMed ID: 12952502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of antibody to current influenza viruses and effect of vaccination on antibody response.
    Pereira MS; Chakraverty P; Schild GC; Coleman MT; Dowdle WR
    Br Med J; 1972 Dec; 4(5842):701-3. PubMed ID: 4646846
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental challenge of chicken vaccinated with commercially available H5 vaccines reveals loss of protection to some highly pathogenic avian influenza H5N1 strains circulating in Hong Kong/China.
    Connie Leung YH; Luk G; Sia SF; Wu YO; Ho CK; Chow KC; Tang SC; Guan Y; Malik Peiris JS
    Vaccine; 2013 Aug; 31(35):3536-42. PubMed ID: 23791547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Properties of the Hong Kong influenza virus. I. General characteristics of the Hong Kong virus.
    Coleman MT; Dowdle WR
    Bull World Health Organ; 1969; 41(3):415-8. PubMed ID: 4985376
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunisation against influenza with a new subunit vaccine tested on children at risk (author's transl)].
    Luthardt T; Lutz O; Kindt H
    Dtsch Med Wochenschr; 1979 Jan; 104(2):56-60. PubMed ID: 759142
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intanza(®) 15 mcg intradermal influenza vaccine elicits cross-reactive antibody responses against heterologous A(H3N2) influenza viruses.
    Ansaldi F; Canepa P; Ceravolo A; Valle L; de Florentiis D; Oomen R; Vogel FR; Denis M; Samson SI; Icardi G
    Vaccine; 2012 Apr; 30(18):2908-13. PubMed ID: 22342501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Live influenza B vaccine in volunteers. A report to the Medical Research Council by their Committee on Influenza and Other Respiratory Virus Vaccines.
    Beare AS; Tyrrell DA; Hobson D; Howells CH; Pereira MS; Pollock TM; Tyler LE
    J Hyg (Lond); 1969 Mar; 67(1):1-11. PubMed ID: 5278156
    [No Abstract]   [Full Text] [Related]  

  • 37. Diversity of the antibody response to the different antigenic determinants on the hemagglutinin subunits of influenza viruses.
    Laver WG; Downie JC; Webster RG
    J Immunol; 1976 Feb; 116(2):336-41. PubMed ID: 55438
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Local and systemic antibody response after vaccination with 3 different types of vaccines against influenza I. Hemagglutinationinhibiting antibodies (author's transl)].
    Kuwert EK; Werner J; Scheiermann N; Pledt T
    Zentralbl Bakteriol Orig A; 1979 Jul; 244(2-3):155-74. PubMed ID: 506543
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunogenicity and efficacy of the monovalent, trivalent and quadrivalent intranasal live attenuated influenza vaccines containing different pdmH1N1 strains.
    Yeolekar LR; Ganguly M; Tyagi P; Ingle NB; Stittelaar KJ; Waal L; Scorza FB; Mahmood K; Dhere RM
    Vaccine; 2018 Nov; 36(46):6944-6952. PubMed ID: 30322745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and immunogenicity of a virus-like particle pandemic influenza A (H1N1) 2009 vaccine: results from a double-blinded, randomized Phase I clinical trial in healthy Asian volunteers.
    Low JG; Lee LS; Ooi EE; Ethirajulu K; Yeo P; Matter A; Connolly JE; Skibinski DA; Saudan P; Bachmann M; Hanson BJ; Lu Q; Maurer-Stroh S; Lim S; Novotny-Diermayr V
    Vaccine; 2014 Sep; 32(39):5041-8. PubMed ID: 25045806
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.